194 filings
Page 7 of 10
8-K
ceyxmubrx fy3twiq
16 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
cz5iqzocwr a8hzytqaw
5 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
9n4e6x0kh82gaa4t s0
5 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
vvnnp9jm4ihaj
9 May 17
Neos Therapeutics Reports First Quarter 2017 Financial Results
12:00am
DEFA14A
im8ktp48
28 Apr 17
Additional proxy soliciting materials
12:00am
S-8
b9nerjl vi81x
15 Mar 17
Registration of securities for employees
12:00am
8-K
y0pejhfz98953 1y74
14 Mar 17
Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
ukffcydt 3ru8p7bshm
10 Mar 17
Entry into a Material Definitive Agreement
12:00am
424B5
vz5hm
3 Feb 17
Prospectus supplement for primary offering
12:00am
8-K
dv1 550k2fw9s
3 Feb 17
Neos Therapeutics Announces Pricing of Underwritten Public
12:00am
424B5
hotn hpdne
2 Feb 17
Prospectus supplement for primary offering
12:00am
8-K
cfl0970w
2 Feb 17
Neos Therapeutics Announces Proposed Offering of Common Stock
12:00am
8-K
0qce38gwm9i94ok898
20 Dec 16
Neos Therapeutics Completes Resubmission of NDA for Cotempla XR-ODT for the Treatment of ADHD
12:00am
8-K
s9zzc5 znmups
10 Nov 16
Neos Therapeutics Reports Third Quarter 2016 Financial Results
12:00am
EFFECT
zve632
12 Aug 16
Notice of effectiveness
12:00am